Position in XERS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,188,451
+$463,451 QoQ
Shares Held
150,057
+20.0% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#80
of 238 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Quarry LP holds $3,286,514 across 21 Drug Manufacturers - Specialty & Generic names. XERS ranks #2 (36.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
25,800 | $2,057,034 | |
| 2 | XERS |
Xeris Biopharma Holdings, Inc.
This page
|
150,057 | $1,188,451 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
151 | $5,235 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
|
93 | $4,325 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
|
404 | $4,040 | |
| 6 | ZTS |
Zoetis Inc.
|
55 | $3,952 | |
| 7 | PAHC |
Phibro Animal Health Corp
|
113 | $3,548 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
101 | $2,562 |
All Filings in XERS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,188,451 | 150,057 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $725,000 | 125,000 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $628,000 | 80,000 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $671,550 | 82,500 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $758,875 | 162,500 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $388,422 | 70,751 | Shares | Other | 2025-05-15 | |
| 2024-06-30 | $67,500 | 30,000 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $65,195 | 29,500 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $47,000 | 20,000 | Shares | Other | 2024-02-20 | |
| No filing history on record for this holder in this stock. | ||||||